publication venue for
- Diverse learners: learning disabilities and quality of life following mind-body and health education interventions for adults with neurofibromatosis.. 167:315-322. 2024
- The impact of a virtual mind-body program on resilience factors among international English-speaking adults with neurofibromatoses: secondary analysis of a randomized clinical trial.. 163:707-716. 2023
- Baseline characteristics of adults with neurofibromatosis enrolled on a psychosocial randomized controlled trial.. 159:637-646. 2022
- Psychosocial profiles of risk and resiliency in neurofibromatoses: a person-centered analysis of illness adaptation.. 156:519-527. 2022
- Psychological resiliency explains the relationship between emotional distress and quality of life in neurofibromatosis.. 155:125-132. 2021
- Depression explains the association between pain intensity and pain interference among adults with neurofibromatosis.. 154:257-263. 2021
- Improvement in resiliency factors among adolescents with neurofibromatosis who participate in a virtual mind-body group program.. 147:451-457. 2020
- Cultivating resiliency in patients with neurofibromatosis 2 who are deafened or have severe hearing loss: a live‑video randomized control trial.. 145:561-569. 2019
- First report of quality of life in adults with neurofibromatosis 2 who are deafened or have significant hearing loss: results of a live-video randomized control trial.. 143:505-513. 2019
- Pineal region glioblastomas display features of diffuse midline and non-midline gliomas.. 140:63-73. 2018
- Virus vector-mediated genetic modification of brain tumor stromal cells after intravenous delivery.. 139:293-305. 2018
- The impact of a mind-body program on multiple dimensions of resiliency among geographically diverse patients with neurofibromatosis.. 137:321-329. 2017
- Clinical and molecular characteristics of gliosarcoma and modern prognostic significance relative to conventional glioblastoma.. 137:303-311. 2017
- Health literacy assessment in adults with neurofibromatosis: electronic and short-form measurement using FCCHL and Health LiTT.. 136:335-342. 2017
- First use of patient reported outcomes measurement information system (PROMIS) measures in adults with neurofibromatosis.. 131:413-419. 2016
- Quality of life among children and adolescents with neurofibromatosis 1: a systematic review of the literature.. 122:219-28. 2015
- Examining perceived cancer risk among patients with neurofibromatosis type 1.. 122:127-33. 2015
- The relaxation response resiliency program (3RP) in patients with neurofibromatosis 1, neurofibromatosis 2, and schwannomatosis: results from a pilot study.. 120:103-9. 2014
- Quality of life among adult patients with neurofibromatosis 1, neurofibromatosis 2 and schwannomatosis: a systematic review of the literature.. 114:257-62. 2013